What is Relay Therapeutics, Inc.'s AOCI?

Relay Therapeutics, Inc. (RLAY) reported AOCI of -$172K in Q1 2026.

How has Relay Therapeutics, Inc.'s AOCI changed year-over-year?

Relay Therapeutics, Inc.'s AOCI decreased by 552.6% year-over-year, from $38K to -$172K.

What is the long-term trend for Relay Therapeutics, Inc.'s AOCI?

Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s AOCI has grown at a 62.8% compound annual growth rate (CAGR), from $64K to $733K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Relay Therapeutics, Inc. RLAY AOCI

AOCI at other companies

Revolution Medicines, Inc.RVMD

-$622K-136%

Ligand PharmaceuticalsLGND

$5.39M+445%

Arcus BiosciencesRCUS

-$1M—

IDEAYA Biosciences, Inc.IDYA

-$494K-131%

Cogent Biosciences, Inc.COGT

-$415K-353%

Tango TherapeuticsTNGX

-$115K-159%

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.8B+300%

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s AOCI?: Relay Therapeutics, Inc. (RLAY) reported AOCI of -$172K in Q1 2026.
How has Relay Therapeutics, Inc.'s AOCI changed year-over-year?: Relay Therapeutics, Inc.'s AOCI decreased by 552.6% year-over-year, from $38K to -$172K.
What is the long-term trend for Relay Therapeutics, Inc.'s AOCI?: Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s AOCI has grown at a 62.8% compound annual growth rate (CAGR), from $64K to $733K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.